Sarah Haller
Foot & Ankle Surgery · Des Plaines, ILNPI 1871910620
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by International Life Sciences at 53.9% of the total. Reporting peaked in 2023 at $13,536 and has fallen 90.3% since, to $1,311 in 2025. Among foot & ankle surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $161.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Life Sciences$14K
- Stryker$4K
- Treace Medical Concepts, Inc.$3K
- Cashflow Solutions, LLC$1K
- Musculoskeletal Transplant Foundation Inc.$591
- Kerecis Limited$539
- plus $3K from 24 others
What the payments were for
- Consulting fees$14,70056%
- Travel & lodging$2,0698%
- Food & beverage$8,02131%
- Education$4852%
- Other$1,0064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| International Life Sciences | 6 | $14,176 |
| Stryker(2 entities) | 34 | $3,847 |
| Treace Medical Concepts, Inc. | 19 | $2,833 |
| Cashflow Solutions, LLC | 2 | $1,020 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $591 |
| Kerecis Limited | 4 | $539 |
| Arthrex | 4 | $513 |
| Integra Lifesciences Corporation | 16 | $502 |
| Seapearl East, Inc | 5 | $421 |
| Smith+Nephew | 15 | $377 |
| Zimmer Biomet | 8 | $246 |
| Organogenesis Inc. | 4 | $173 |
| Paragon 28, Inc. | 5 | $171 |
| Medline Industries LP | 1 | $148 |
| Royal Biologics, Inc. | 3 | $135 |
| Amgen(2 entities) | 7 | $103 |
| Johnson & Johnson | 2 | $98 |
| Ossio Inc | 1 | $97 |
| Alfasigma USA, Inc. | 6 | $79 |
| Dynasplint Systems Inc. | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $30 |
| Orthofix Medical, Inc. | 1 | $16 |
| KCI USA, Inc. | 1 | $16 |
| Bioventus LLC | 1 | $15 |
| Celularity Inc. | 1 | $15 |
| Avanos Medical | 1 | $14 |
| Merck | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXBAND$13,829
- Lapiplasty System$2,210
- Lympha Press Optimal Plus(US) BT$1,006
- PCD-51 731A (US) - White$1,006
- PCD-52 737A (US) White$1,006
- PROstep$979
- Kerecis Omega3 SurgiClose$859
- INTEGRA$836
- Kerecis Omega3 Marigen$680
- CITREFIX$591
- ORTHOLOC 2 LAPIFUSE$402
- INTEGRA DERMAL REGENERATION TEMPLATE$279
- PRIMATRIX$279
- VARIAX$276
- AUGMENT INJECTABLE$272
- Kerecis Omega3 GraftGuide$250
- INFINITY$179
- Kerecis Omega3 Wound$167
- Viaflow$151
- VITOSS$149
How this compares
$26,281 in reported general payments places this provider in the 90th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 45 | $45,154 |
| Ketoconazole | 401 | $6,750 |
| Ciclopirox | 36 | $984 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $765 |
| Terbinafine Hcl | 61 | $621 |
| Gabapentin | 58 | $544 |
| Ammonium Lactate | 44 | $474 |
| Methylprednisolone | 60 | $350 |
| Triamcinolone Acetonide | 22 | $248 |
| Meloxicam | 52 | $154 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $103 |
| Cephalexin | 13 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $30 | $45,15445 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 555 foot & ankle surgery providers in Illinois.
Other foot & ankle surgery in Des Plaines
- Timothy McConnDes Plaines$48K
- Lowell WeilDes Plaines$43K
- Douglas PacaccioRockford$4.1M
- Anand VoraLibertyville$3.2M
- Lowell WeilMount Prospect$2.2M
- Matthew SorensenAlgonquin$1.1M
- Edgardo Rodriguez CollazoChicago$755K
- David GarrasOrland Park$658K
- Patrick McEneaneyCary$570K
- Brian BurgessNaperville$488K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.